ArticleBMC medicine2020

Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries.

Xiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.